 |
인쇄하기
취소
|
Dong-A Pharm to introduce Elaspol injection, the word's first drug for acute lung injury in ...
Dong-A Pharm to introduce Elaspol injection, the word's first drug for acute lung injury in early 2005
Dong-A Pharm announced recently it entered into an exclusive licensing agreement with Japan's Ono Pharmaceutical Co. for the local marketing of Elaspol injection (sivelestat sodium), the world's first drug for acute lung injury associated with systemic inflammatory response syndrome (SIRS),...
Dong-A Pharm announced recently it entered into an exclusive licensing agreement with Japan's Ono Pharmaceutical Co. for the local marketing of Elaspol injection (sivelestat sodium), the world's first drug for acute lung injury associated with systemic inflammatory response syndrome (SIRS),...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.